S. Tjulandin : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (155)
Les plus populaires
Liste
- Liste
- Tableau

1

Tamoxifen Never Ceases to Amaze: New Findings on Non-Estrogen Receptor Molecular Targets and Mediated Effects

Bogush, Tatiana Anatolievna, Polezhaev, Boris Borisovich, Mamichev, Ivan Andreevich, Bogush, Elena Alexandrovna, Polotsky, Boris Evseevich, Tjulandin, Sergei Alexeevich, Ryabov, Andrey Borisovich

Journal:

Cancer Investigation

Année:

2018

Langue:

english

Fichier:

PDF, 656 KB

english, 2018

2

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

Luca Gianni, Wolfgang Eiermann, Vladimir Semiglazov, Alexey Manikhas, Ana Lluch, Sergey Tjulandin, Milvia Zambetti, Federico Vazquez, Mikhail Byakhow, Mikhail Lichinitser, Miguel Angel Climent, Eva Ci

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 124 KB

english, 2010

3

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Von Hoff, Daniel D., Ervin, Thomas, Arena, Francis P., Chiorean, E. Gabriela, Infante, Jeffrey, Moore, Malcolm, Seay, Thomas, Tjulandin, Sergei A., Ma, Wen Wee, Saleh, Mansoor N., Harris, Marion, Reni

Journal:

New England Journal of Medicine

Année:

2013

Langue:

english

Fichier:

PDF, 637 KB

english, 2013

4

High incidence of mutations inBRCA1 and BRCA2genes in ovarian cancer

T. Yu. Smirnova, N. I. Pospekhova, L. N. Lyubchenko, S. A. Tjulandin, R. F. Gar’kavtseva, E. K. Ginter, A. V. Karpukhin

Journal:

Bulletin of Experimental Biology and Medicine

Année:

2007

Langue:

english

Fichier:

PDF, 271 KB

english, 2007

5

Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study

Price, Timothy J, Peeters, Marc, Kim, Tae Won, Li, Jin, Cascinu, Stefano, Ruff, Paul, Suresh, Atilli Satya, Thomas, Anne, Tjulandin, Sergei, Zhang, Kathy, Murugappan, Swaminathan, Sidhu, Roger

Journal:

The Lancet Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 592 KB

english, 2014

6

Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study

Iveson, Timothy, Donehower, Ross C, Davidenko, Irina, Tjulandin, Sergey, Deptala, Andrzej, Harrison, Mark, Nirni, Somanath, Lakshmaiah, Kuntegowdanahalli, Thomas, Anne, Jiang, Yizhou, Zhu, Min, Tang,

Journal:

The Lancet Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 339 KB

english, 2014

7

1406PFinal results of the concordance analysis of PD-L1 immunohistochemistry (IHC) assays and polymerase chain reaction (PCR) in non-small lung cancer (NSCLC) patients

Tsimafeyeu, I, Imyanitov, E N, Zavalishina, L, Raskin, G, Povilaitite, P, Savelov, N, Kharitonova, E, Rumyantsev, A, Pugach, I, Andreeva, Y, Petrov, A, Frank, G, Tjulandin, S

Journal:

Annals of Oncology

Année:

2018

Langue:

english

Fichier:

PDF, 81 KB

english, 2018

8

507PDPOSEIDON PHASE I/II TRIAL: ABITUZUMAB COMBINED WITH CETUXIMAB PLUS IRINOTECAN AS SECOND-LINE TREATMENT FOR PATIENTS WITH KRAS WILD-TYPE METASTATIC COLORECTAL CANCER

Élez, E., Kocáková, I., Höhler, T., Martens, U.M., Bokemeyer, C., Van Cutsem, E., Melichar, B., Smakal, M., Cso˝szi, T., Topuzov, E., Orlova, R., Tjulandin, S., Rivera, F., Straub, J., Bruns, R., Quar

Journal:

Annals of Oncology

Année:

2014

Fichier:

PDF, 72 KB

2014

9

Treatment outcome of patients with brain metastases from malignant germ cell tumors

Sophie D. Fosså, Carsten Bokemeyer, Arthur Gerl, Stephane Culine, William G. Jones, Graham M. Mead, José R. Germa-Luch, Jörg Pont, Hans J. Schmoll, Sergei Tjulandin

Journal:

Année:

1999

Langue:

english

Fichier:

PDF, 124 KB

english, 1999

10

HERV-K(HML-2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors

Anna Kleiman, Natalia Senyuta, Alexey Tryakin, Marlies Sauter, Apollon Karseladze, Sergei Tjulandin, Vladimir Gurtsevitch, Nikolaus Mueller-Lantzsch

Journal:

International Journal of Cancer

Année:

2004

Langue:

english

Fichier:

PDF, 225 KB

english, 2004

11

Paclitaxel and cisplatin as salvage treatment in patients with non-seminomatous germ cell tumour who failed to achieve a complete remission on induction chemotherapy

S.A. Tjulandin, D.A. Titov, V.V. Breder, N.J. Sidorova, A.J. Popov, D.Z. Kupchan, A.M. Garin

Journal:

Clinical Oncology

Année:

1998

Langue:

english

Fichier:

PDF, 318 KB

english, 1998

12

A phase II study of pemetrexed and carboplatin in patients with locally advanced or metastatic breast cancer

August Garin, Alexey Manikhas, Mikhail Biakhov, Mikhail Chezhin, Tatiana Ivanchenko, Kurt Krejcy, Vera Karaseva, Sergey Tjulandin

Journal:

Breast Cancer Research and Treatment

Année:

2008

Langue:

english

Fichier:

PDF, 195 KB

english, 2008

13

Targeted therapy in the treatment of solid tumors: Practice contradicts theory

N. V. Zhukov, S. A. Tjulandin

Journal:

Biochemistry (Moscow)

Année:

2008

Langue:

english

Fichier:

PDF, 168 KB

english, 2008

14

Weekly nab-paclitaxel is safe and effective in ≥65 years old patients with metastatic breast cancer: A post-hoc analysis

Matti Aapro, Sergei Tjulandin, Paul Bhar, William Gradishar

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 235 KB

english, 2011

15

Epoetin Theta with a New Dosing Schedule in Anaemic Cancer Patients Receiving Nonplatinum-Based Chemotherapy: A Randomised Controlled Trial

Sergei A. Tjulandin, Peter Bias, Reiner Elsässer, Beate Gertz, Erich Kohler, Anton Buchner

Journal:

Archives of Drug Information

Année:

2011

Langue:

english

Fichier:

PDF, 306 KB

english, 2011

16

Epoetin Theta in Anaemic Cancer Patients Receiving Platinum-Based Chemotherapy: A Randomised Controlled Trial

Sergei A. Tjulandin, Peter Bias, Reiner Elsässer, Beate Gertz, Erich Kohler, Anton Buchner

Journal:

Archives of Drug Information

Année:

2010

Langue:

english

Fichier:

PDF, 352 KB

english, 2010

17

914 The role of a cytoreductive surgery in nonseminomatous germ cell tumor patients with small retroperitoneal mass after induction chemotherapy

S.A. Karpov, S.A. Tjulandin, G.V. Molchanov, A.M. Garin

Journal:

European Journal of Cancer

Année:

1995

Langue:

english

Fichier:

PDF, 159 KB

english, 1995

18

920 Secondary leukemia caused by etoposide containing chemotherapy in germ cell cancer patients

S.A. Tjulandin, A.M. Garin

Journal:

European Journal of Cancer

Année:

1995

Langue:

english

Fichier:

PDF, 151 KB

english, 1995

19

Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study

V. Semiglazov, W. Eiermann, M. Zambetti, A. Manikhas, A. Bozhok, A. Lluch, S. Tjulandin, M.D. Sabadell, A. Caballero, P. Valagussa, J. Baselga, L. Gianni

Journal:

European Journal of Surgical Oncology (EJSO)

Année:

2011

Langue:

english

Fichier:

PDF, 152 KB

english, 2011

20

Paclitaxel + BEP (T-BEP) Regimen as Induction Chemotherapy in Poor Prognosis Patients With Nonseminomatous Germ Cell Tumors: A Phase II Study

A. Tryakin, M. Fedyanin, D. Kanagavel, I. Fainstein, J. Sergeev, B. Polockij, V. Matveev, T. Zakharova, A. Garin, S. Tjulandin

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 305 KB

english, 2011

21

168 - Paclitaxel (P) and cisplatin (C) as salvage treatment for nonseminomatous germ cell tumor (NSGCT) patients (pts)

S. Tjulandin, D. Titov, V. Breder, N. Sidorova, A. Popov, A. Garin

Journal:

European Journal of Cancer

Année:

1997

Langue:

english

Fichier:

PDF, 265 KB

english, 1997

22

Gemzar (GEM) + Mitimycin C (MMC) in patients with advanced pancreatic cancer (APC)

I. Bazin, A. Garin, J. Bulat, M. Narimanov, D. Nosov, D. Titov, A. Popov, R. Nasyrova, S. Tjulandin

Journal:

European Journal of Cancer

Année:

1999

Langue:

english

Fichier:

PDF, 162 KB

english, 1999

23

51A Docetaxel (D), cisplatin (C) 5-fluorouracil (F) compared to cisplatin (C) and 5-fluorouracil (F) for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma (MGC): Interim results of a randomized phase III trial (V325)

E. Van Cutsem, V. Moiseyenko, S. Tjulandin, M. Fodor, C. Boni, E. Zuber, S. Assadourian

Journal:

European Journal of Cancer Supplements

Année:

2003

Langue:

english

Fichier:

PDF, 170 KB

english, 2003

24

198 Combination of docetaxel with 5-fluorouracil and cisplatin in patients with advanced gastric cancer (AGC)

M. Narimanov, I. Bazin, A. Tryakin, D. Titov, S. Tjulandin, A. Garin

Journal:

European Journal of Cancer Supplements

Année:

2003

Langue:

english

Fichier:

PDF, 155 KB

english, 2003

25

841 Prognostic factors in advanced nonseminomatous germ cell tumors (NSGCT): Importance of primary tumor (PT) histology and numbers of negative prognostic factors (NPF)

A. Tryakin, S. Tjulandin, O. Scherbakova, D. Nosov, M. Narimanov, V. Goutnik, A. Garin

Journal:

European Journal of Cancer Supplements

Année:

2003

Langue:

english

Fichier:

PDF, 160 KB

english, 2003

26

Intravenous and oral ibandronate have better safety and tolerability profiles than zoledronic acid: evidence from comparative phase III trials

B. Bergström, Lichinitser, S. Tjulandin, J.-J. Body

Journal:

European Journal of Cancer Supplements

Année:

2006

Langue:

english

Fichier:

PDF, 138 KB

english, 2006

27

Phase III trial of oral ibandronate and intravenous zoledronic acid in breast cancer patients with bone metastases: comparative bone turnover marker and safety data

J.-J. Body, Lichinitser, S. Tjulandin, B. Bergström

Journal:

European Journal of Cancer Supplements

Année:

2006

Langue:

english

Fichier:

PDF, 269 KB

english, 2006

28

2108 POSTER Cardiac safety of trastuzumab in combination with epirubicin/ cyclophosphamide as first-line therapy in patients with HER2-positive metastatic breast cancer

M. Untch, S. Tjulandin, W. Jonat, H. Meerpohl, M. Lichinitser, G.M. Manikhas, F. Jänicke, M. Muscholl, M. Pauschinger, M. Lehle

Journal:

European Journal of Cancer Supplements

Année:

2007

Langue:

english

Fichier:

PDF, 62 KB

english, 2007

29

2030 ORAL Efficacy of neoadjuvant trastuzumab in patients with inflammatory breast cancer: data from the NOAH (NeOAdjuvant Herceptin) Phase III trial

J. Baselga, V. Semiglazov, G.M. Manikhas, W. Eiermann, A. Lluch, S. Tjulandin, A. Feyereislova, B. Vanhauwere, P. Valagussa, L. Gianni

Journal:

European Journal of Cancer Supplements

Année:

2007

Langue:

english

Fichier:

PDF, 60 KB

english, 2007

30

INTRATHORACIC GERM CELL TUMOURS: TREATMENT RESULTS AND LONG-TERM FOLLOW-UP

M. Volkova, A. Tjulandin, B. Polotskiy, B. Ahmedov, V. Matveev

Journal:

European Urology Supplements

Année:

2006

Langue:

english

Fichier:

PDF, 53 KB

english, 2006

31

Immunological detection, characterization and prognostic value of circulating tumor cells in patients with advanced breast cancer

O. Bzhaduq, N. Tupitsyn, S. Tjulandin, L. Grivtsova

Journal:

European Journal of Cancer Supplements

Année:

2008

Langue:

english

Fichier:

PDF, 71 KB

english, 2008

32

Comparison of weekly and every-3-week nab-paclitaxel in elderly patients with metastatic breast cancer

M. Aapro, S. Tjulandin, P. Bhar, W. Gradishar

Journal:

European Journal of Cancer Supplements

Année:

2008

Langue:

english

Fichier:

PDF, 57 KB

english, 2008

33

Retrospective analysis of patients with poor prognostic factors and metastatic breast cancer in a phase III study comparing nab-paclitaxel to solvent-based paclitaxel

T. Camburn, S. Tjulandin, N. Davidson, J. O'Shaughnessy, P. Bhar, W. Gradishar

Journal:

European Journal of Cancer Supplements

Année:

2008

Langue:

english

Fichier:

PDF, 56 KB

english, 2008

34

Randomized comparisons of weekly versus every-3-week nab-paclitaxelin patients with metastatic breast cancer

J. O'Shauqhnessv, M. Lichinitser, S. Tjulandin, N. Davidson, H. Shaw, P. Bhar, W. Gradishar

Journal:

European Journal of Cancer Supplements

Année:

2008

Langue:

english

Fichier:

PDF, 75 KB

english, 2008

35

Surgical aspect in NOAH Phase III trial (neoadjuvant trastuzumab in HER2-positive locally advanced breast cancer)

V. Semiqlazov, W. Eiermann, A. Manikhas, A. Bozok, A. Lluch, S. Tjulandin, A. Feyereislova, P. Valagussa, J. Baselga, L. Gianni

Journal:

European Journal of Cancer Supplements

Année:

2008

Langue:

english

Fichier:

PDF, 69 KB

english, 2008

36

Overall survival analysis of a randomized phase III trial comparing nab-paclitaxel with solvent-based paclitaxel in patients with metastatic breast cancer previously treated with anthracycline

N. Davidson, S. Tjulandin, J. O'Shaughnessy, P. Bhar, W. Gradishar

Journal:

European Journal of Cancer Supplements

Année:

2008

Langue:

english

Fichier:

PDF, 59 KB

english, 2008

37

502 POSTER Modification of cisplatin administration schedule in FLEP preoperative chemotherapy improved response to the chemotherapy in patients with locally-advanced esophageal cancer

T.A. Bogush, B.E. Polotskiy, E.A. Bogush, I.A. Pokataev, E.O. Ignatova, S.A. Tjulandin, M.I. Davydov

Journal:

European Journal of Cancer Supplements

Année:

2008

Langue:

english

Fichier:

PDF, 72 KB

english, 2008

38

5000 A 3-arm randomised phase II study of oral vinorelbine (NVBo) plus capecitabine (X) versus NVBo and X in sequential versus docetaxel (D) plus X in patients with metastatic breast cancer (MBC) previously treated with anthracyclines

M. Campone, N. Dobrovolskaya, S. Tjulandin, S.C. Chen, S.J. Fourié, F. Mefti, M. Konstantinova, J.C. Pouget, F. Lefresne, J. Jassem

Journal:

European Journal of Cancer Supplements

Année:

2009

Langue:

english

Fichier:

PDF, 47 KB

english, 2009

39

487 Efficacy of first-line capecitabine plus bevacizumab in patients with ER/PgR-positive metastatic breast cancer (MBC) and those previously treated with hormone therapy

V. Diéras, V. Semiglazov, S. Tjulandin

Journal:

European Journal of Cancer Supplements

Année:

2010

Langue:

english

Fichier:

PDF, 48 KB

english, 2010

40

485 Influence of disease free interval on the efficacy of capecitabine-bevacizumab for HER2-negative metastatic breast cancer (MBC) in the RIBBON-1 trial

A. Brufsky, O. Ponomarova, S. Tjulandin

Journal:

European Journal of Cancer Supplements

Année:

2010

Langue:

english

Fichier:

PDF, 49 KB

english, 2010

41

Effect of the timing of orchiectomy on survival in patients with metastatic germ cell tumors of testis

Fedyanin, Mikhail, Tryakin, Alexey, Bulanov, Anatoly, Fainshtein, Igor, Zakharova, Tatiana, Matveev, Vsevolod, Garin, August, Tjulandin, Sergei

Journal:

Urologic Oncology: Seminars and Original Investigations

Année:

2014

Langue:

english

Fichier:

PDF, 278 KB

english, 2014

42

Late relapses (>2 years) in patients with stage I testicular germ cell tumors: Predictive factors and survival

Fedyanin, Mikhail, Tryakin, Alexey, Kanagavel, Dheepak, Bulanov, Anatoly, Burova, Alena, Figurin, Konstantin, Fainshtein, Igor, Sergeev, Uriy, Zakharova, Tatiana, Garin, August, Tjulandin, Sergei

Journal:

Urologic Oncology: Seminars and Original Investigations

Année:

2013

Langue:

english

Fichier:

PDF, 230 KB

english, 2013

43

A Phase III Randomized Equivalence Study of Biosimilar Filgrastim versus Amgen Filgrastim in Patients Receiving Myelosuppressive Chemotherapy for Breast Cancer

Waller, Cornelius F., Semiglazov, Vladimir F., Tjulandin, Sergei, Bentsion, Dmitry, Chan, Stephen, Challand, Rodeina

Journal:

Année:

2010

Fichier:

PDF, 1.17 MB

2010

44

Prognostic factors and efficacy of different chemotherapeutic regimens in patients with mediastinal nonseminomatous germ cell tumors

Fedyanin, Mikhail, Tryakin, Alexey, Mosyakova, Yana, Pokataev, Ilya, Bulanov, Anatoly, Zakharova, Tatiana, Polockii, Boris, Garin, August, Tjulandin, Sergey

Journal:

Journal of Cancer Research and Clinical Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 418 KB

english, 2014

45

Phase I, dose-finding study of AZD8931, an inhibitor of EGFR (erbB1), HER2 (erbB2) and HER3 (erbB3) signaling, in patients with advanced solid tumors

Tjulandin, S., Moiseyenko, V., Semiglazov, V., Manikhas, G., Learoyd, M., Saunders, A., Stuart, M., Keilholz, U.

Journal:

Investigational New Drugs

Année:

2014

Langue:

english

Fichier:

PDF, 313 KB

english, 2014

46

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort

Gianni, Luca, Eiermann, Wolfgang, Semiglazov, Vladimir, Lluch, Ana, Tjulandin, Sergei, Zambetti, Milvia, Moliterni, Angela, Vazquez, Federico, Byakhov, Mikhail J, Lichinitser, Mikhail, Climent, Miguel

Journal:

The Lancet Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 294 KB

english, 2014

47

5041 POSTER Non-dysgerminomas of the ovary: a retrospective analysis at N.N. Blokhin Russian Cancer Research Center

Streltsova, O., Jordaniya, K., Kuznetsov, V., Bulanov, A., Kedrova, A., Tjulandin, S.

Journal:

European Journal of Cancer Supplements

Année:

2007

Langue:

english

Fichier:

PDF, 75 KB

english, 2007

48

Lack of cardiotoxicity in metastatic breast cancer (MBC) patients (pts) receiving doxorubicin/Paclitaxel (DOX/PAC) combination

Osmanova, L., Stecenko, A., Stenina, M., Kassil, V., Garin, A., Tjulandin, S.

Journal:

European Journal of Cancer

Année:

1999

Langue:

english

Fichier:

PDF, 148 KB

english, 1999

49

6504 ORAL Safety and Efficacy of Epirubicin, Cisplatin, and Capecitabine (ECX) Plus Rilotumumab (R) as First-line Treatment for Unresectable Locally Advanced (LA) or Metastatic (M) Gastric or Esophagogastric Junction (EGJ) Adenocarcinoma

Iveson, T., Donehower, R.C., Davidenko, I., Tjulandin, S., Deptala, A., Harrison, M., Loh, E., Jiang, Y., Oliner, K., Dubey, S.

Journal:

European Journal of Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 44 KB

english, 2011

50

7166 POSTER Validation of the Prognostic Score System for Survival in Patients (pts) With Relapses of Metastatic Nonseminomatous Germ Cell Tumours (mNGCT) After Induction Chemotherapy (iCT)

Fedianin, M., Tryakin, A., Kanagavel, D., Zakharova, T., Fainstein, I., Figurin, K., Sergeev, U., Garin, A., Tjulandin, S.

Journal:

European Journal of Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 42 KB

english, 2011